COVID-19 Update

Intravacc and Celonic Partner for COVID-19 Vaccine Development

July 30, 2020

The companies will combine Intravacc’s OMV delivery platform with S-proteins with Celonic’s CHOvolution mammalian cell expression system to produce B and T-cell responses against SARS-CoV-2.

Avacta, Daewoong Pharmaceutical Expand Collaboration to Include COVID-19 Therapy

July 30, 2020

Avacta Group has expanded its partnership with Daewoong Pharmaceutical to include Affimer molecules that target viruses, such as coronavirus.

EMA Starts Review of Dexamethasone as COVID-19 Treatment

July 30, 2020

EMA has started a review of dexamethasone as a treatment for adults with COVID-19 who require respiratory support and have been admitted to hospital.

Sterling Pharma Signs Agreement to Support COVID-19 Treatment Development

July 29, 2020

Sterling Pharma Solutions has signed a deal with Moleculin Biotech to support the development of WP1122, a potential COVID-19 treatment.

UK Government Provides Cash Boost for COVID-19 Vaccine Manufacture

July 23, 2020

The UK government is committing a further £100 million (US $127 million) to ensure that there is capability to manufacture a successful COVID-19 vaccine at scale in the UK.

EMA Sets Up Infrastructure to Support Real-World Monitoring of COVID-19 Vaccines

July 23, 2020

The European Medicines Agency has set up an infrastructure to support real-world monitoring of the efficacy and safety of COVID-19 vaccines and treatments.

LabVantage COVID-19 LIMS Solution Launched for Workplace Health and Safety

July 23, 2020

An LIMS system enables a COVID-19 testing center for employees at their workplace.

Pfizer and BioNTech Sign Supply Agreement with US Government for Vaccine Candidate

July 22, 2020

Pending approval of the Pfizer and BioNTech mRNA-based vaccine candidate against SARS-COV-2, the companies will supply the US government with an initial 100 million doses.

Drug Pricing Back in the Spotlight

July 21, 2020

Should therapies and vaccines be cheap or free in a pandemic and would that really dry up innovation?

AstraZeneca and IQVIA Partner on Potential COVID-19 Vaccine

July 21, 2020

The project will focus on providing a faster route to clinical studies for AstraZeneca’s potential COVID-19 vaccine, AZD1222.